JW Lifescience Corporation (KRX:234080)
14,720
+90 (0.62%)
Dec 18, 2025, 11:10 AM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 226.54 billion as of December 17, 2025. Its market cap has increased by 29.35% in one year.
Market Cap
226.54B
Enterprise Value
249.59B
Revenue
248.30B
Ranking
n/a
PE Ratio
4.76
Stock Price
14,720.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 226.54B, a decrease of -33.38%. That is a compound annual growth rate of -4.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 226.54B | 34.47% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | 328.57B | 4.80% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.03T |
| Celltrion | 41.09T |
| ALTEOGEN | 22.65T |
| ABL Bio | 10.50T |
| SK Biopharmaceuticals | 10.35T |
| Yuhan | 8.59T |
| LigaChem Biosciences | 6.27T |
| HLB Co., Ltd. | 6.19T |